B6.129-Tardbpem2.1(TARDBP)H/H

Status

Available to order

EMMA IDEM:14603
Citation informationRRID:IMSR_EM:14603 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6.129-Tardbpem2.1(TARDBP)H/H
Alternative nameB6;129-Tardbp em2.1(TARDBP)H/H
Strain typeEndonuclease-mediated
Allele/Transgene symbolTardbpem2.1(TARDBP)H
Gene/Transgene symbolTardbp

Information from provider

ProviderElizabeth Fisher
Provider affiliationUCL QS Motor Neuron Disease Centre
Additional ownerAbraham Acevedo, University Hospital of the Canary Islands, Tenerife, Spain
Genetic informationThe official allele designation is Tardbp
Phenotypic informationHomozygous:
No overt phenotyping. No aging has been performed at the time of submission. These mice can be used as a template to introduce amyotrophic lateral sclerosis (ALS) mutations and study the impact of such mutations when endogenously expressed - notably, not overexpressed like all other existing models that express human TARDBP variants. In fact this is the only mouse model that exclusively expresses the human and not the endogenous TARDBP protein, as other human TARDBP-expressing transgenic lines have not been viable on a Tardbp null background. This is important for studies aiming at understanding strains of misfolding of the human TDP-43 protein. Work from the prion field shows distinct pathological strains of mouse and human Prnp proteins and therefore it is important to study human TDP43 in the absence of the mouse orthologue. The vast majority of ALS cases exhibit TDP43 pathology (cytoplasmic mislocalisation and aggregation) in the absence of TARDBP mutations, via known and unknown mechanisms, which could be studied in these mice. Such triggers of TDP43 pathology could include genetic (e.g. C9orf72 expansion) and/or environmental (e.g. cellular stress) factors.

Heterozygous:
No overt phenotyping. No aging has been performed at the time of submission.
Breeding historyAt least 5 generations of backcrossing to the C57BL/6J genetic background have been performed.
References
  • Generation and analysis of innovative genomically humanized knockin SOD1, TARDBP (TDP-43), and FUS mouse models.;Devoy Anny, Price Georgia, De Giorgio Francesca, Bunton-Stasyshyn Rosie, Thompson David, Gasco Samanta, Allan Alasdair, Codner Gemma F, Nair Remya R, Tibbit Charlotte, McLeod Ross, Ali Zeinab, Noda Judith, Marrero-Gagliardi Alessandro, Brito-Armas José M, Williams Chloe, Öztürk Muhammet M, Simon Michelle, O'Neill Edward, Bryce-Smith Sam, Harrison Jackie, Atkins Gemma, Corrochano Silvia, Stewart Michelle, Gilthorpe Jonathan D, Teboul Lydia, Acevedo-Arozena Abraham, Fisher Elizabeth M C, Cunningham Thomas J, ;2021;iScience;24;103463; 34988393
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreMary Lyon Centre at MRC Harwell, Oxford, United Kingdom

Disease and phenotype information

IMPC phenotypes (gene matching)
  • decreased blood urea nitrogen level / IMPC
  • decreased bone mineral content / IMPC
  • preweaning lethality, complete penetrance / IMPC
  • decreased mean platelet volume / IMPC
  • decreased bone mineral density / IMPC
  • abnormal startle reflex / IMPC
  • embryonic lethality prior to organogenesis / IMPC
MGI phenotypes (gene matching)
  • increased body weight / MGI
  • abnormal locomotor behavior / MGI
  • impaired coordination / MGI
  • abnormal eating behavior / MGI
  • polyphagia / MGI
  • abnormal object recognition memory / MGI
  • limb grasping / MGI
  • abnormal learning/memory/conditioning / MGI
  • abnormal motor capabilities/coordination/movement / MGI
  • increased vertical activity / MGI
  • no phenotypic analysis / MGI
  • impaired muscle relaxation / MGI
  • abnormal GABAergic neuron morphology / MGI
  • nervous system phenotype / MGI
  • decreased stereotypic behavior / MGI
  • abnormal brain interneuron morphology / MGI
  • abnormal muscle tone / MGI
  • behavior/neurological phenotype / MGI
  • slow postnatal weight gain / MGI
  • decreased grip strength / MGI
  • prenatal lethality, complete penetrance / MGI
  • embryonic lethality, complete penetrance / MGI
  • embryonic lethality between implantation and somite formation, complete penetrance / MGI
  • preweaning lethality, incomplete penetrance / MGI
  • absent inner cell mass proliferation / MGI
  • embryonic lethality prior to organogenesis / MGI
  • abnormal cognition / MGI
  • cognitive inflexibility / MGI

Literature references

  • Generation and analysis of innovative genomically humanized knockin SOD1, TARDBP (TDP-43), and FUS mouse models.;Devoy Anny, Price Georgia, De Giorgio Francesca, Bunton-Stasyshyn Rosie, Thompson David, Gasco Samanta, Allan Alasdair, Codner Gemma F, Nair Remya R, Tibbit Charlotte, McLeod Ross, Ali Zeinab, Noda Judith, Marrero-Gagliardi Alessandro, Brito-Armas José M, Williams Chloe, Öztürk Muhammet M, Simon Michelle, O'Neill Edward, Bryce-Smith Sam, Harrison Jackie, Atkins Gemma, Corrochano Silvia, Stewart Michelle, Gilthorpe Jonathan D, Teboul Lydia, Acevedo-Arozena Abraham, Fisher Elizabeth M C, Cunningham Thomas J, ;2021;iScience;24;103463; 34988393

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*
  • Tissue - Types of tissue, service fee and delivery time available upon request

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable), as well as a CRISPR surcharge.

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
MTA will be issued after an order has been submitted.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).